311 related articles for article (PubMed ID: 10379634)
1. The effect of four different antihypertensive medications on cardiovascular regulation in hypertensive sleep apneic patients--assessment by spectral analysis of heart rate and blood pressure variability.
Salo TM; Kantola I; Voipio-Pulkki LM; Pelttari L; Viikari JS
Eur J Clin Pharmacol; 1999 May; 55(3):191-8. PubMed ID: 10379634
[TBL] [Abstract][Full Text] [Related]
2. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing.
Pelttari LH; Hietanen EK; Salo TT; Kataja MJ; Kantola IM
Am J Hypertens; 1998 Mar; 11(3 Pt 1):272-9. PubMed ID: 9544866
[TBL] [Abstract][Full Text] [Related]
3. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea.
Kraiczi H; Hedner J; Peker Y; Grote L
Am J Respir Crit Care Med; 2000 May; 161(5):1423-8. PubMed ID: 10806134
[TBL] [Abstract][Full Text] [Related]
4. Effect of hypotensive drugs on the circadian blood pressure pattern in essential hypertension: a comparative study.
Zakopoulos N; Stamatelopoulos S; Moulopoulos S
Cardiovasc Drugs Ther; 1997 Dec; 11(6):795-9. PubMed ID: 9512875
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of losartan and enalapril, alone or with a diuretic, on ambulatory blood pressure and cardiac performance in hypertension: a case-control study.
Verdecchia P; Schillaci G; Reboldi GP; Sacchi N; Bruni B; Benemio G; Porcellati C
Blood Press Monit; 2000 Jun; 5(3):187-93. PubMed ID: 10915233
[TBL] [Abstract][Full Text] [Related]
6. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive sympathoplegic therapy to ACE inhibition in Blacks with congestive heart failure: a comparison of alpha-1 with beta-1 blockade on exercise tolerance and cardiac sympathovagal reflex activity.
Ajayi AA; Sofowora GG; Adigun AQ; Asiyanbola B
Ethn Dis; 2003; 13(1):71-9. PubMed ID: 12723015
[TBL] [Abstract][Full Text] [Related]
8. Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function.
Schiffrin EL; Park JB; Pu Q
J Hypertens; 2002 Jan; 20(1):71-8. PubMed ID: 11791028
[TBL] [Abstract][Full Text] [Related]
9. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
Hakamäki T; Lehtonen A
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
[TBL] [Abstract][Full Text] [Related]
10. Autonomic function and baroreflex sensitivity during angiotensin-converting enzyme inhibition or angiotensin II AT-1 receptor blockade in essential hypertensive patients.
Guasti L; Petrozzino MR; Mainardi LT; Grimoldi P; Zanotta D; Garganico D; Diolisi A; Simoni C; Grandi AM; Gaudio G; Cerutti S; Venco A
Acta Cardiol; 2001 Oct; 56(5):289-95. PubMed ID: 11712824
[TBL] [Abstract][Full Text] [Related]
11. Combined effects of the angiotensin II antagonist candesartan cilexetil (TCV-116) and other classes of antihypertensive drugs in spontaneously hypertensive rats.
Wada T; Sanada T; Ojima M; Kanagawa R; Nishikawa K; Inada Y
Hypertens Res; 1996 Dec; 19(4):247-54. PubMed ID: 8986455
[TBL] [Abstract][Full Text] [Related]
12. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
[TBL] [Abstract][Full Text] [Related]
13. Evidence of increased sympathetic vasomotor drive with shorter acting dihydropyridine calcium channel antagonists in human hypertension: a study using spectral analysis of RR interval and systolic arterial pressure variability.
Lucini D; Mela GS; Malliani A; Pagani M
J Cardiovasc Pharmacol; 1997 May; 29(5):676-83. PubMed ID: 9213212
[TBL] [Abstract][Full Text] [Related]
14. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and dynamic interactions of the angiotensin-converting enzyme inhibitor imidapril with hydrochlorothiazide, bisoprolol and nilvadipine.
Breithaupt-Grögler K; Ungethüm W; Meurer-Witt B; Belz GG
Eur J Clin Pharmacol; 2001 Jul; 57(4):275-84. PubMed ID: 11549204
[TBL] [Abstract][Full Text] [Related]
16. Effects of antihypertensive medication on hypertension in patients with sleep apnoea.
Pelttari L; Rauhala E; Kantola I
Blood Press Suppl; 1994; 2():88-91. PubMed ID: 8061854
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
19. The effects of rilmenidine and atenolol on mental stress, dynamic exercise and autonomic function in mild to moderate hypertension.
Panfilov V; Morris AD; Donnelly R; Scemama M; Reid JL
Br J Clin Pharmacol; 1995 Dec; 40(6):563-9. PubMed ID: 8703663
[TBL] [Abstract][Full Text] [Related]
20. Goals of antihypertensive therapy.
McVeigh GE; Flack J; Grimm R
Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
